申请人:Novo Nordisk A/S
公开号:US05478845A1
公开(公告)日:1995-12-26
Piperidine derivatives of formula ##STR1## wherein A is straight or branched alkyl, alkoxy-alkyl, or alkenyl; X is O or NH; Y is O, S, NH, NCN, or N-alkyl; R.sup.1 is 6-fluoro-1,2-benzisoxazol-3-yl, 6-fluoro-1H-indazol-3-yl, or 6-fluoro-1-methyl-1H-indazol-3-yl; R.sup.2 is alkyl or phenyl; and R.sup.3 is phenyl optionally substituted, or R.sup.3 is ##STR2## wherein Z represents a 5- or 6-membered heterocyclic ring; or R.sup.2 and R.sup.3 together with the nitrogen atom form a fused heterocyclic ring system; or pharmaceutically acceptable salts thereof are useful in the treatment of indications related to the CNS-system, cardiovascular system or to gastrointestinal disorders.
式子为##STR1##的哌啶衍生物,其中A是直链或支链烷基,烷氧基烷基或烯基;X是O或NH;Y是O、S、NH、NCN或N-烷基;R1是6-氟-1,2-苯并异噁唑-3-基、6-氟-1H-吲唑-3-基或6-氟-1-甲基-1H-吲唑-3-基;R2是烷基或苯基;R3是苯基,可选地被取代,或R3是##STR2##其中Z代表5-或6-成员杂环环;或R2和R3与氮原子一起形成融合的杂环环系;或其药学上可接受的盐在治疗与中枢神经系统、心血管系统或胃肠道疾病相关的适应症方面有用。